# The Role of the Microbiota in the Systemic Immune Response

> **NCT02340182** · NA · COMPLETED · sponsor: **W.J. Wiersinga, MD, PhD** · enrollment: 12 (actual)

## Conditions studied

- Healthy
- Sepsis

## Interventions

- **DRUG:** Vancomycin
- **DRUG:** Ciprofloxacin
- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT02340182
- **Lead sponsor:** W.J. Wiersinga, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02340182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02340182, "The Role of the Microbiota in the Systemic Immune Response". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02340182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*